FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response.

MLA

Bogatyrova, Olga, et al. “FGFR1 Overexpression in Non-Small Cell Lung Cancer Is Mediated by Genetic and Epigenetic Mechanisms and Is a Determinant of FGFR1 Inhibitor Response.” European Journal of Cancer (Oxford, England : 1990), vol. 151, July 2021, pp. 136–49. EBSCOhost, https://doi.org/10.1016/j.ejca.2021.04.005.

APA

Bogatyrova, O., Mattsson, J. S. M., Ross, E. M., Sanderson, M. P., Backman, M., Botling, J., Brunnström, H., Kurppa, P., La Fleur, L., Strell, C., Wilm, C., Zimmermann, A., Esdar, C., & Micke, P. (2021). FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response. European Journal of Cancer (Oxford, England : 1990), 151, 136–149. https://doi.org/10.1016/j.ejca.2021.04.005

Chicago

Bogatyrova, Olga, Johanna S M Mattsson, Edith M Ross, Michael P Sanderson, Max Backman, Johan Botling, Hans Brunnström, et al. 2021. “FGFR1 Overexpression in Non-Small Cell Lung Cancer Is Mediated by Genetic and Epigenetic Mechanisms and Is a Determinant of FGFR1 Inhibitor Response.” European Journal of Cancer (Oxford, England : 1990) 151 (July): 136–49. doi:10.1016/j.ejca.2021.04.005.